C12N 2795/10031
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2795/10031 (Uses of virus other than therapeutic or vaccine) appears on 15 US grants and 26 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 26
- Assignees
- 18
- Inventors
- 55
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 2 | 5 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 2 | 1 |
| 2023 | 2 | 5 |
| 2024 | 2 | 2 |
| 2025 | 1 | 4 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Devices and methods for detecting microorganisms using recombinant reproduction-deficient indicator bacteriophage9 Dec 2025US 12,492,421 B2Laboratory Corporation of America Holdings
- Protease activity profiling via programmable phage display of comprehensive proteome-scale peptide libraries17 Sep 2024US 12,091,776 B2The John Hopkins University
- Method for purification of bacteriophage particles11 Jun 2024US 12,006,517 B2Adaptive Phage Therapeutics, Inc.
- Devices and methods for detecting microorganisms using recombinant reproduction-deficient indicator bacteriophage29 Aug 2023US 11,739,363 B2Laboratory Corporation of America Holdings
- Visual continuous spatial directed evolution method18 Jul 2023US 11,702,764 B2Shenzhen Institutes of Advanced Technology
- Devices and Methods for Detecting Microorganisms Using Recombinant Reproduction-Deficient Indicator Bacteriophage12 Mar 2026US 2026/0071250 A1
- Bacteria-targeting capsid particle, treatment composition, disinfectant, food, bacteria elimination method, bactericidal method, corrosion prevention method, animal treatment method, gene introduction method, bacteria function addition method, method for producing bacteria-targeting capsid particle, and method for producing nucleic acid for bacteria-targeting capsid particle25 Dec 2025US 2025/0387442 A1Jichi Medical University
- Lytic phage with high specificity towards pathogenic escherichia coli22 May 2025US 2025/0164483 A1
- Bacteriophages for Protection from Ultraviolet Irradiation1 May 2025US 2025/0134802 A1The Board of Trustees of the Leland Stanford Junior University
- Method of Generating Phage Clones with Expanded Activity13 Feb 2025US 2025/0051733 A1
Most cited
By later US patents
- Listeria monocytogenes bacteriophages and uses thereof6US 8,685,697 B1Intralytix, Inc. · 2014
- Recombinant B11 bacteriophages and uses thereof1US 10,329,539 B1The Charles Stark Draper Laboratory, Inc. · 2019
- Composition of matter: engineering of Escherichia coli phage K1E1US 11,268,072 B2The Charles Stark Draper Laboratory, Inc. · 2022
- Devices and methods for detecting microorganisms using recombinant reproduction-deficient indicator bacteriophage1US 11,739,363 B2Laboratory Corporation of America Holdings · 2023
- Recombinant phages and proteins1US 9,404,922 B2The Rockefeller University · 2016